Murata S, Nakamura M, Sugihara K, Sakai T, Ishioka K, Takahashi S, et al. The Change in Neutrophil-to-lymphocyte Ratio after Initiation of Nivolumab Monotherapy May be a Strong Marker of Response and Predictor of Prognosis in Advanced Non-small Cell Lung Carcinoma. Asian Pac J Cancer Care [Internet]. 2022 Mar. 8 [cited 2026 Jun. 21];7(1):191-6. Available from: http://waocp.com/journal/index.php/apjcc/article/view/725